Shionogi Shionogi (塩野義製薬株式会社) is a pharmaceutical company developing treatments for infectious, pain, and chronic liver diseases. | ||
Founding Date | Founding Date 1863 | Founding Date 1878 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Osaka, JP HQ Beijing, CN Hong Kong, HK Amagasaki, JP Amagasaki, JP Kanegasaki, JP Misato, JP see more | |
Employees | Employees 88,5021% decrease | Employees 4,955 |
Valuation ($) | Valuation ($) 27.1 b | Valuation ($) 12.3 b |
Financial | ||
Revenue (est.) | Revenue (est.) €45.6b (FY, 2025) | Revenue (est.) ¥499.7b (FY, 2026) |
Cost of goods | Cost of goods €14b (FY, 2025) | Cost of goods ¥55.5b (FY, 2026) |
Gross profit | Gross profit €32.5b (FY, 2025) | Gross profit ¥491.3b (FY, 2026) |
Net income | Net income (€3.6b) (FY, 2025) | Net income ¥205.9b (FY, 2026) |
Funding | ||
Total funding raised | Total funding raised $ 3.5b | Total funding raised $ 4.7m |
Shionogi (塩野義製薬株式会社) is a pharmaceutical company developing treatments for infectious, pain, and chronic liver diseases.
View company